Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Saw, Sanjay ^a   Kale, Sagar Laxman ^a   Arora, Naveen ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; 8 ISOPROSTANE; DEXAMETHASONE; EOSIN; EOSINOPHIL PEROXIDASE; HEMATOXYLIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PEPTIDOLEUKOTRIENE; SERINE PROTEINASE INHIBITOR;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; EOSINOPHIL COUNT; FEMALE; GOBLET CELL; HISTOPATHOLOGY; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PERIODIC ACID SCHIFF STAIN; PROPHYLAXIS; PROTEIN DEGRADATION; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHIL PEROXIDASE; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOTRIENES; MICE; MICE, INBRED BALB C; NEUTROPHILS; OVALBUMIN; OXIDATIVE STRESS; SERINE PROTEINASE INHIBITORS; SULFONES;

MUS;

EID: 84864032913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041107     Document Type: Article

References (49)

1. Gupta R, Sharma V, Sridhara S, Singh BP, Arora N, (2004) Identification of serine protease as a major allergen of Curvularia lunata. Allergy 59: 421-427.
2. Koblinski JE, Ahram M, Sloane BF, (2000) Unraveling the role of proteases in cancer. Clin Chim Acta 291: 113-135.
3. Sudha VT, Arora N, Gaur SN, Pasha S, Singh BP, (2008) Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana. Allergy 63: 768-776.
4. Reed CE, Kita H, (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114: 997-1008.
5. Hewitt CR, Foster S, Phillips C, Horton H, Jones RM, et al. (1998) Mite allergens: significance of enzymatic activity. Allergy 53: 60-63.
6. Shen HD, Lin WL, Tam MF, Wang SR, Tzean SS, et al. (1999) Characterization of allergens from Penicillium oxalicum and P. notatum by immunoblotting and N-terminal amino acid sequence analysis. Clin Exp Allergy 29: 642-651.
7. Kauffman HF, (2003) Interaction of environmental allergens with airway epithelium as a key component of asthma. Curr Allergy Asthma Rep 3: 101-108.
8. Sudha VT, Arora N, Singh BP, (2009) Serine protease activity of Per a 10 augments allergen-induced airway inflammation in a mouse model. Eur J Clin Invest 39: 507-516.
9. Goel C, Govindaraj D, Singh BP, Farooque A, Kalra N, et al. (2012) Serine protease Per a 10 from Periplaneta americana bias dendritic cells towards type 2 by upregulating CD86 and low IL-12 secretions. Clin Exp Allergy 42: 412-422.
10. Krishna MT, Chauhan A, Little L, Sampson K, Hawksworth R, et al. (2001) Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol 107: 1039-1045.
11. Herbert CA, King CM, Ring PC, Holgate ST, Stewart GA, et al. (1995) Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol 12: 369-378.
12. Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, et al. (1999) Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104: 123-133.
13. Schmidlin F, Amadesi S, Dabbagh K, Lewis DE, Knott P, et al. (2002) Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 169: 5315-5321.
14. Post S, Nawijn MC, Hackett TL, Baranowska M, Gras R, et al. (2011) The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation. Thorax.
15. Balldin G, Ohlsson K, Balldin G, Ohlsson K, (1979) Trasylol prevents trypsin-induced shock in dogs. Hoppe Seylers Z Physiol Chem 360: 651-656.
16. Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, et al. (2002) Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol 128: 229-234.
17. Imada T, Komorita N, Kobayashi F, Naito K, Yoshikawa T, et al. (2002) Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn J Pharmacol 90: 214-217.
18. Tomimori Y, Tsuruoka N, Fukami H, Saito K, Horikawa C, et al. (2002) Role of mast cell chymase in allergen-induced biphasic skin reaction. Biochem Pharmacol 64: 1187-.
19. Izakovicova HL, Kankova K, Znojil V, (2009) Haplotype analysis of the NADPH oxidase p22 phox gene in patients with bronchial asthma. Int Arch Allergy Immunol 148: 73-80.
20. Shen HD, Tam MF, Tang RB, Chou H, (2007) Aspergillus and Penicillium allergens: focus on proteases. Curr Allergy Asthma Rep 7: 351-356.
21. Bisht V, Arora N, Singh BP, Pasha S, Gaur SN, et al. (2004) Epi p 1, an allergenic glycoprotein of Epicoccum purpurascens is a serine protease. FEMS Immunol Med Microbiol 42: 205-211.
22. Tripathi P, Kukreja N, Singh BP, Arora N, (2009) Serine protease activity of Cur l 1 from Curvularia lunata augments Th2 response in mice. J Clin Immunol 29: 292-302.
23. Gough L, Schulz O, Sewell HF, Shakib F, (1999) The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. J Exp Med 190: 1897-1902.
24. Wenzel SE, Fowler AA III, Schwartz LB, (1988) Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 137: 1002-1008.
25. Simpson JL, Scott RJ, Boyle MJ, Gibson PG, (2005) Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 172: 559-565.
26. Inoue K, Takano H, Yoshikawa T, (2005) Protease-antiprotease imbalance in inflammatory diseases in the lung. Chest 128: 1069.
27. He S, Gaca MD, Walls AF, (1998) A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 286: 289-297.
28. He S, Gaca MD, Walls AF, (2001) The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur J Pharmacol 412: 223-229.
29. Oh SW, Pae CI, Lee DK, Jones F, Chiang GK, et al. (2002) Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 168: 1992-2000.
30. Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, et al. (2006) Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J Allergy Clin Immunol 118: 105-112.
31. Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H, (2000) Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol 121: 77-85.
32. Tournoy KG, Kips JC, Pauwels RA, Tournoy KG, Kips JC, et al. (2000) Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy 30: 775-783.
33. He S, Walls AF, (1997) Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 328: 89-97.
34. Saito K, Nagata M, Kikuchi I, Sakamoto Y, (2004) Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin. Ann Allergy Asthma Immunol 93: 594-600.
35. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B, Dahlen SE, et al. (1980) Leukotrienes are potent constrictors of human bronchi. Nature 288: 484-486.
36. Liu YC, Khawaja AM, Rogers DF, Liu YC, Khawaja AM, et al. (1998) Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro. Br J Pharmacol 124: 563-571.
37. Ishizaki M, Tanaka H, Kajiwara D, Toyohara T, Wakahara K, et al. (2008) Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma. J Pharmacol Sci 108: 355-363.
38. Nadeem A, Masood A, Siddiqui N, (2008) Oxidant-antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options. Ther Adv Respir Dis 2: 215-235.
39. Kawikova I, Barnes PJ, Takahashi T, Tadjkarimi S, Yacoub MH, et al. (1996) 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 153: 590-596.
40. Megyeri P, Pabst KM, Pabst MJ, (1995) Serine protease inhibitors block priming of monocytes for enhanced release of superoxide. Immunology 86: 629-635.
41. Wijayanti N, Kietzmann T, Immenschuh S, (2005) Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes. J Biol Chem 280: 21820-21829.
42. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, Pick E, et al. (1997) Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272: 13292-13301.
43. Conseil V, Soete M, Dubremetz JF, Conseil V, Soete M, et al. (1999) Serine protease inhibitors block invasion of host cells by Toxoplasma gondii. Antimicrob Agents Chemother 43: 1358-1361.
44. Megyeri P, Nemeth L, Pabst KM, Pabst MJ, Deli MA, et al. (1999) 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-alpha-induced blood-brain barrier opening. Eur J Pharmacol 374: 207-211.
45. Nakamura Y, Hoshino M, Sim JJ, Ishii K, Hosaka K, et al. (1998) Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 53: 835-841.
46. Mehta AK, Gaur SN, Arora N, Singh BP, (2007) Effect of choline chloride in allergen-induced mouse model of airway inflammation. Eur Respir J 30: 662-671.
47. Kukreja N, Sridhara S, Singh BP, Arora N, (2008) Effect of proteolytic activity of Epicoccum purpurascens major allergen, Epi p 1 in allergic inflammation. Clin Exp Immunol 154: 162-171.
48. Sudha VT, Arora N, Gaur SN, Pasha S, Singh BP, (2008) Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana. Allergy 63: 768-776.
49. Zarnowski R, Connolly PA, Wheat LJ, Woods JP, Zarnowski R, et al. (2007) Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates. Diagn Microbiol Infect Dis 59: 39-47.